Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma. (Q53608819)

16 May 2018

title

Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma. (English)

1 reference

16 May 2018

author name string

Jianwei Zhang

1

1 reference

16 May 2018

Wenfeng Fang

2

1 reference

16 May 2018

Tao Qin

3

1 reference

16 May 2018

Yunpeng Yang

4

1 reference

16 May 2018

Shaodong Hong

5

1 reference

16 May 2018

Wenhua Liang

6

1 reference

16 May 2018

Yuxiang Ma

7

1 reference

16 May 2018

Hongyun Zhao

8

1 reference

16 May 2018

Yan Huang

9

1 reference

16 May 2018

Cong Xue

10

1 reference

16 May 2018

Peiyu Huang

11

1 reference

16 May 2018

Zhihuang Hu

12

1 reference

16 May 2018

Yuanyuan Zhao

13

1 reference

16 May 2018

Li Zhang

14

1 reference

16 May 2018

publication date

22 February 2015

1 reference

16 May 2018

published in

Medical Oncology

1 reference

16 May 2018

volume

32

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

86

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-015-0501-6

exact match

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Immunotherapy earns its spot in the ranks of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0501-6

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

21 January 2018

1 reference

12 December 2020

Nasopharyngeal cancer

1 reference

12 December 2020

PD-1: an inhibitory immunoreceptor involved in peripheral tolerance

1 reference

12 December 2020

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival

1 reference

12 December 2020

The prevalence and prevention of nasopharyngeal carcinoma in China.

1 reference

12 December 2020

Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells

1 reference

12 December 2020

10.1007/S12032-015-0501-6

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25702326

1 reference

16 May 2018